Articles
-
GPEx® Lightning: Stable Cell Line Development For Complex Biologics
6/5/2026
GPEx® Lightning delivers stable cell pools in 25 days, titers exceeding 15g/L for mAbs and 11g/L for bispecifics, and 60+ generations of stability — compressing timelines by 6–12 weeks.
-
ADCs Are Reshaping Cancer Treatment
6/4/2026
The future of ADCs depends on more than breakthrough science. Learn what sponsors now expect from CDMOs to accelerate development, reduce risk, and support commercial success.
-
The Many Benefits Of Outsourcing Stability: A Baxter
6/2/2026
Outsourcing stability testing improved efficiency, reduced costs, and enhanced scalability, enabling robust lifecycle support, regulatory compliance, and optimized resource utilization across programs.
-
Faster Production Of Panbela's Pancreatic Cancer Drug
6/2/2026
Process innovation reduced synthesis steps, increased yield, and improved chiral purity, enabling faster, scalable manufacturing of a pancreatic cancer therapy for clinical and commercial development.
-
Developing A Multi-Drug Antiparasitic For Dogs
6/2/2026
Complex formulation enabled a multi-drug antiparasitic therapy for dogs, achieving stability, palatability, and scalable clinical supply across multiple strengths within accelerated timelines.
-
From Lab To Tox Batch: A First-Time-Right API Scale-Up
6/2/2026
Gain insight into a first-time-right process that improved yield and scalability, advancing a vascular calcification inhibitor from lab scale to tox and GMP manufacturing for clinical development.
-
Madison: Clinical, Commercial Drug Substance Development
6/2/2026
Catalent Madison offers gene-to-GMP drug substance in 8 months via GPEx Lightning CHO cell lines, hitting 15+ g/L, backed by 24 approved products and 5 GMP trains up to 4,000 L.
-
A Green Synthesis Process For A Growth Promoter Drug For Animals
6/2/2026
Green chemistry redesigned a growth promoter synthesis, cutting waste and costs while boosting yield, efficiency, and sustainability for scalable animal health manufacturing.
-
Accelerating A Novel Treatment For Erectile Dysfunction
6/2/2026
Integrated development advanced a novel erectile dysfunction therapy from discovery to clinical trials, delivering scalable manufacturing and strong safety, efficacy, and patient potential.
-
Partnering For Analytical Excellence
6/1/2026
Analytical development services provide method development, validation, and stability testing, ensuring regulatory compliance, data integrity, and high-quality support across the lifecycle.